USPTO serial 79345481
CURVE THERAPEUTICS
Reviewed by CopyMark Law Group
Status 654
- Filing date
- Status date
- Registration date
- —
- Examiner
- DIBLE, JONATHON I
- Law office
- TMO LAW OFFICE 111
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CURVE THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations in the nature of biologically compatible chemical substances for scientific purposes, namely, for scientific, laboratory, clinical, and medical research; biological tissue, namely, mammalian soft and hard tissues comprising or derived from stem cells or progenitor cells for scientific, laboratory, clinical and medical research; biological tissue, namely, biological tissue comprising or derived from stem cells or progenitor cells, and compositions thereof, for scientific, laboratory, clinical and medical research | ACTIVE | — |
| 005 | Pharmaceuticals, namely, pharmaceutical preparations for the treatment of cancer and neurological diseases; medical and veterinary preparations for treatment of cancer and neurological diseases; sanitary preparations for medical purposes; dietetic food and dietetic preparations adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; pharmaceuticals for use in oncology for the treatment of cancer and neurological diseases | ACTIVE | — |
| 042 | Drug discovery and pharmaceutical drug development services; scientific services in the nature of scientific research, analysis, and testing in the field of pharmaceuticals and research, development and design relating thereto; medical research; technological services in the nature of pharmaceutical products development and technical consulting in the field of pharmaceutical studies and research and design relating thereto; product design and development of medical technology in the field of pharmaceuticals; product design and development of medical diagnostic apparatus; consultancy services in the field of technological development in the field of medical technology and pharmaceuticals; industrial analysis and industrial research services in the field of medical technology and pharmaceuticals; design and development of computer hardware and software in the field of clinical trials for pharmaceuticals; design and development of software in the field of clinical trials for pharmaceuticals; clinical research, namely, conducting clinical trials for others; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies, immuno-oncology, inflammation, haematology and infectious disease; medical and scientific research, namely, conducting clinical trials for others; conducting clinical trials for pharmaceutical products for others; scientific screening and assaying, namely, scientific research; chemical analysis; chemical research; biotechnology research; consultancy in the field of biotechnology | ACTIVE | — |
| 044 | Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health services relating to antibodies, immuno-oncology, inflammation, haematology and infectious disease, namely, medical diagnostic testing, monitoring and reporting services; medical screening and assaying in the nature of medical testing for diagnostic or treatment purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 8, 2026 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 3, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| May 2, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| May 2, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 1, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Oct 29, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Oct 29, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 13, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 27, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 27, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 13, 2023 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 15, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 15, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 15, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 13, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 12, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 12, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 2, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 6, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 14, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 14, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 29, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 18, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 17, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 9, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 26, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 22, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 21, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |